Genuity Science Investor
Some of the world's most advanced clinico-omic data and insights to enable better disease discovery to improve human health.
Founded Date:
2013-01-01
Technology:
Cancer
Funding Status:
M&A
Total Funding:
455000000.0
Employee Number:
101-250
Headquarters:
Boston, Massachusetts, United States
Last Funding Date:
2018-11-27
Investors Number:
8.0
Zip:
NA
Last Funding Type:
Series C
Estimated Revenue:
$10M to $50M
Acquisitions Number:
Made Acquisitions, Was Acquired
Industry:
End-to-End Drug Development